Ultragenyx Pharmaceutical Inc. <RARE.O>: Piper Sandler cuts target price to $35 from $68
RARE•Related News
Nasdaq trade halt continues <NXXT.O> halt news pending at 03:28 AM
NXXT•
Nasdaq trade halt continues <HUBCZ.O> halt news pending at 03:28 AM
HUBC•
Nasdaq Trade Halt Continues <ATAI.O> Reason Not Available at 03:28 AM
ATAI•
Halozyme CEO Helen Torley reports disposal of common shares worth USD 6.5 million
HALO•
Nasdaq trade halt continues <MCTA.O> reason not available at 03:28 AM
MCTA•